Leap therapeutics reports third quarter 2021 financial results

Cambridge, mass., nov. 12, 2021 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended september 30, 2021.

LPTX Ratings Summary

LPTX Quant Ranking